技术面，港股科技无法继续横盘！

Group 1 - The core viewpoint of the articles highlights a significant rally in the Hong Kong stock market, particularly in the technology sector, with notable gains in innovative drug stocks and major tech companies like Alibaba, Xiaomi, and Tencent [1][5][9] - The Hang Seng Technology Index has shown a narrow trading range over the past two months, indicating a potential breakout due to the upward trend in the market [1][3] - The Hong Kong stock market has experienced substantial volatility and structural differentiation, with strong performances in new consumption and innovative drugs, while AI and major players like Alibaba and Meituan faced challenges [5][6] Group 2 - The Hong Kong Technology Index has a broader coverage compared to the Hang Seng Technology Index, with a higher allocation in software and pharmaceuticals, benefiting from the growth in AI and innovative drugs [3] - The Hong Kong IPO market has been robust, with 46 companies listed in the first half of the year, raising a total of HKD 113.2 billion (approximately USD 14.4 billion), surpassing the total for the entire year of 2024 [9] - Southbound capital has significantly increased its net purchases of Hong Kong stocks, amounting to HKD 725.973 billion year-to-date, indicating its growing influence on the market [6][9]